Clinical Trial Information Request for Protocol 22-213 Title A Phase 2 Study of AGEN1423, an Anti-CD73-TGF?-Trap Bifunctional Antibody, in Combination with Botensilimab, with or without Chemotherapy in Subjects with Advanced Pancreatic Cancer. PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone